We are live on ! Find out more
VLKIM

Van Lanschot Kempen Investment Management Portfolio holdings

AUM $13.1B
1-Year Est. Return 19.56%
This Fund
S&P 500
This Quarter Est. Return
+2.43%
1 Year Est. Return
+19.56%
3 Year Est. Return
+75.92%
5 Year Est. Return
+98.44%
10 Year Est. Return
+233.43%
AUM
$11.7B
AUM Growth
+$472M
Cap. Flow
+$306M
Cap. Flow %
2.62%
Top 10 Hldgs %
41.08%
Holding
261
New
17
Increased
107
Reduced
120
Closed
11

Top Buys

Rank Stock Value
1
BRO icon
Brown & Brown
BRO
+$216M
2
ICLR icon
Icon
ICLR
+$132M
3
ZTS icon
Zoetis
ZTS
+$120M
4
LEN icon
Lennar Class A
LEN
+$113M
5
SPOT icon
Spotify
SPOT
+$59.1M

Sector Composition

Rank Sector Weight
1 Technology 28.03%
2 Financials 21.66%
3 Consumer Discretionary 13.42%
4 Communication Services 13.36%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCG icon
226
PG&E
PCG
$39.5B
$1.78M 0.02%
110,915
+54,474
+97% +$870K
TDW icon
227
Tidewater
TDW
$4.63B
$1.47M 0.01%
29,154
+13,918
+91% +$735K
LINE
228
Lineage Inc
LINE
$9.01B
$1.35M 0.01%
+38,598
New +$1.43M
RNR icon
229
RenaissanceRe
RNR
$13.7B
$1.18M 0.01%
4,191
-54,135
-93% -$14.2M
DRH icon
230
Diamondrock Hospitality Co
DRH
$2.6B
$1.04M 0.01%
116,142
-43,006
-27% -$366K
WBD icon
231
Warner Bros
WBD
$72.4B
$837K 0.01%
29,059
-48,650
-63% -$1.14M
MSA icon
232
Mine Safety
MSA
$7.39B
$305K ﹤0.01%
+1,902
New +$310K
HUM icon
233
Humana
HUM
$47.1B
$267K ﹤0.01%
1,044
+31
+3% +$8.13K
MCK icon
234
McKesson
MCK
$104B
$244K ﹤0.01%
297
-229
-44% -$187K
ELV icon
235
Elevance Health
ELV
$86.6B
$243K ﹤0.01%
694
-4,346
-86% -$1.47M
RCI icon
236
Rogers Communications
RCI
$19.7B
$153K ﹤0.01%
4,044
-41,938
-91% -$1.57M
FOX icon
237
Fox Class B
FOX
$25.4B
$150K ﹤0.01%
2,317
INTU icon
238
Intuit
INTU
$95.2B
$118K ﹤0.01%
178
+24
+16% +$15.9K
VRTX icon
239
Vertex Pharmaceuticals
VRTX
$139B
$117K ﹤0.01%
257
+16
+7% +$6.9K
AMP icon
240
Ameriprise Financial
AMP
$49.1B
$110K ﹤0.01%
224
-24,157
-99% -$11.5M
AZO icon
241
AutoZone
AZO
$47.9B
$105K ﹤0.01%
31
-1,786
-98% -$6.75M
REGN icon
242
Regeneron Pharmaceuticals
REGN
$83.2B
$89.5K ﹤0.01%
116
-6,202
-98% -$4.21M
LII icon
243
Lennox International
LII
$13.5B
$79.2K ﹤0.01%
163
-12,107
-99% -$6.06M
PCAR icon
244
PACCAR
PCAR
$66.6B
$69.6K ﹤0.01%
636
-52,010
-99% -$5.33M
FDS icon
245
Factset
FDS
$10.8B
$63.3K ﹤0.01%
218
-20,423
-99% -$5.73M
BMY icon
246
Bristol-Myers Squibb
BMY
$137B
$54.7K ﹤0.01%
1,014
-34,486
-97% -$1.66M
FSV icon
247
FirstService
FSV
$6.16B
$52.3K ﹤0.01%
336
LULU icon
248
lululemon athletica
LULU
$13.1B
$45.3K ﹤0.01%
218
CF icon
249
CF Industries
CF
$19B
$38.9K ﹤0.01%
503
-41,066
-99% -$3.37M
DOV icon
250
Dover
DOV
$27.2B
$36.1K ﹤0.01%
185
-10,039
-98% -$1.83M

Similar funds

Van Lanschot Kempen Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, Van Lanschot Kempen Investment Management held 261 positions worth $11.7B, up 4.2% from $11.2B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Van Lanschot Kempen Investment Management's Q4 2025 filing shows 17 new, 107 increased, 120 reduced and 11 closed positions. Its largest new stake was Icon: 743,548 shares worth $135M. The largest sale was Citigroup, an estimated $246M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Van Lanschot Kempen Investment Management's largest Q4 2025 buy was Icon: 743,548 shares worth $135M.
  • Van Lanschot Kempen Investment Management added most to Brown & Brown in Q4 2025, an estimated $216M increase.
  • Van Lanschot Kempen Investment Management's biggest Q4 2025 reduction was Citigroup, cutting an estimated $246M.
  • Van Lanschot Kempen Investment Management fully exited Hologic in Q4 2025, selling an estimated $27.7M.
  • Van Lanschot Kempen Investment Management's ten largest holdings make up 41% of its $11.7B portfolio in Q4 2025.
  • Van Lanschot Kempen Investment Management opened 17 new positions and closed 11 in Q4 2025.
  • Van Lanschot Kempen Investment Management's portfolio value rose 4.2% quarter-over-quarter to $11.7B.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.